Aġġorna l-Konferenza dwar l-Ematoloġija / Onkoloġija

AĠĠORNAMENT Hämatologie / Onkologie 2021

Aġġorna l-Ematoloġija / Onkoloġija 2024. Kompli bil-programm. Kompli bl-informazzjoni għall-isponsors u l-esebituri. Kompli bir-reġistrazzjoni. Abbona għan-newsletter tagħna hawn! Miżuri tal-Covid-19 biex tipparteċipa f'Hamburg Aħna qegħdin hawn biex ngħinu! Radisson Blu Hotel Hamburg. Aġġornament 2023. Aġġornament Ematoloġija u Onkoloġija virtwali. Kun l-ewwel li tattendi.100%AĠĠORNAMENT Virtwali fl-ematoloġija/l-onkoloġija

A concept of hygiene for the Congress is not yet clear due to the dynamic pandemic. We will put in place a plan that is appropriate for the situation as soon as it becomes foreseeable. We will notify you of any possible measures in advance.

Ikklikkja fuq il-buttuna hawn taħt biex issir taf aktar dwar l-iġjene ġenerali.

GSK hija mexxejja internazzjonali tal-kura tas-saħħa li tiffoka fuq ir-riċerka. Il-missjoni tagħha hija li ttejjeb il-kwalità tal-ħajja tan-nies billi tgħinhom jgħixu stili ta' ħajja aktar b'saħħithom, itwal u aktar attivi. L-għan tagħna huwa li nkunu waħda mill-kumpaniji tal-kura tas-saħħa l-aktar qawwija, innovattivi u fdati fid-dinja.

GSK is a pioneer in the field of prevention with its comprehensive portfolios of respiratory therapies and vaccines. ViiV Healthcare, our subsidiary, is also active in HIV. We are also one of the leading manufacturers of consumer healthcare products. Our research and developments are focused on immune science, genetics, and advanced technologies. Our current focus is on developing new drugs in the areas related to respiratory diseases and HIV/infectious disease, oncology, and inflammatory immune disorders.